GnRH evokes localized subplasmalemmal calcium signaling in gonadotropes

Molecular Endocrinology

Volumn 28, Issue 12, 2014, Pages 2049-2059

  Dang, An K ^a   Murtazina, Dilyara A ^a   Magee, Christianne ^a   Navratil, Amy M ^b   Clay, Colin M ^a   Amberg, Gregory C ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; ACTIN; CALCIUM; CALCIUM CHANNEL L TYPE; GONADORELIN; GONADORELIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NICARDIPINE; PROTEIN KINASE C; PYRROLE DERIVATIVE;

ACTIN FILAMENT; ALPHAT3 1 CELL LINE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HYPOPHYSIS CELL; MOLECULAR DYNAMICS; TOTAL INTERNAL REFLECTION FLUORESCENCE MICROSCOPY; VOLTAGE CLAMP TECHNIQUE; ANIMAL; CELL LINE; DRUG EFFECTS; ELECTROPHYSIOLOGY; GONADOTROPIN SECRETING CELL; METABOLISM; MOUSE;

ANIMALS; CALCIUM SIGNALING; CELL LINE; ELECTROPHYSIOLOGY; GONADOTROPHS; GONADOTROPIN-RELEASING HORMONE; MICE; MICROSCOPY, FLUORESCENCE; NICARDIPINE; PYRROLES;

EID: 84914106781     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1208     Document Type: Article

References (40)

1. Counis R, Laverrière JN, Garrel G, et al. Gonadotropin-releasing hormone and the control of gonadotrope function. Reprod Nutr Dev. 2005;45(3):243-254.
2. Grosse R, Schmid A, Schoneberg T, et al. Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins. J Biol Chem. 2000;275(13): 9193-9200.
3. Naor Z. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Front Neuroendocrinol. 2009;30(1):10-29.
4. Roberson MS, Misra-Press A, Laurance ME, Stork PJ, Maurer RA. A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone. Mol Cell Biol. 1995;15(7):3531-3539.
5. Mulvaney JM, Zhang T, Fewtrell C, Roberson MS. Calcium influx through L-type channels is required for selective activation of extracellular signal-regulated kinase by gonadotropin-releasing hormone. J Biol Chem. 1999;274(42):29796-29804.
6. Mulvaney JM, Roberson MS. Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin-releasing hormone. J Biol Chem. 2000;275(19):14182-14189.
7. White BR, Duval DL, Mulvaney JM, Roberson MS, Clay CM. Homologous regulation of the gonadotropin-releasing hormone receptor gene is partially mediated by protein kinase C activation of an activator protein-1 element. Mol Endocrinol. 1999;13(4):566-577.
8. Amberg GC, Earley S, Glapa SA. Local regulation of arterial L-type calcium channels by reactive oxygen species. Circ Res. 2010;107(8): 1002-1010.
9. Amberg GC, Navedo MF, Nieves-Cintrón M, Molkentin JD, Santana LF. Calcium sparklets regulate local and global calcium in murine arterial smooth muscle. J Physiol. 2007;579(Pt 1):187-201.
10. 2+ channels. Proc Natl Acad Sci USA. 2005; 102(31):11112-11117.
11. Windle JJ, Weiner RI, Mellon PL. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol. 1990;4(4):597-603.
12. 2+ sparklet activity in arterial smooth muscle. J Gen Physiol. 2006;127(6):611-622.
13. Chaplin NL, Amberg GC. Hydrogen peroxide mediates oxidantdependent stimulation of arterial smooth muscle L-type calcium channels. Am J Physiol Cell Physiol. 2012;302(9):C1382-C1393.
14. Maravall M, Mainen ZF, Sabatini BL, Svoboda K. Estimating intracellular calcium concentrations and buffering without wavelength ratioing. Biophys J. 2000;78(5):2655-2667.
15. 2+ channels during hypertension and Timothy syndrome. Circ Res. 2010;106(4):748-756.
16. 2+ channel sparklets in arterial smooth muscle. Microcirculation. 2013;20(4): 290-298.
17. 2+ channel activator, in cardiac and vascular preparations. Mol Pharmacol. 1991;40(5):734-741.
18. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266(24):15771-15781.
19. Gekeler V, Boer R, Überall F, et al. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Br J Cancer. 1996;74(6): 897-905.
20. Dobkin-Bekman M, Rahamin-Ben Navi L, Shterntal B, et al. Differential role of PKC isoforms in GnRH and phorbol 12-myristate 13-acetate activation of extracellular signal-regulated kinase and Jun N-terminal kinase. Endocrinology. 2010;151(10):4894-4907.
21. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ. Inhibition of protein kinase C by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 1996; 392(2):77- 80.
22. Navratil AM, Knoll JG, Whitesell JD, Tobet SA, Clay CM. Neuroendocrine plasticity in the anterior pituitary: gonadotropin-releasing hormone-mediated movement in vitro and in vivo. Endocrinology. 2007;148(4):1736-1744.
23. Navratil AM, Dozier MG, Whitesell JD, Clay CM, Roberson MS. Role of cortactin in dynamic actin remodeling events in gonadotrope cells. Endocrinology. 2014;155(2):548-557.
24. Davidson L, Pawson AJ, Millar RP, Maudsley S. Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem. 2004;279(3):1980-1993.
25. Hille B. Ion Channels of Excitable Membranes. 3rd ed. Suderland, MA: Sinauer Associates, Inc; 2001.
26. 2+ signaling amplification by oligomerization of L-type Cav1.2 channels. Proc Natl Acad Sci USA. 2012;109(5):1749-1754.
27. 2+ sparklets and angiotensin II-induced hypertension. Circ Res. 2008;102(2):e1- e11.
28. Santana LF, Navedo MF, Amberg GC, Nieves-Cintrón M, Votaw VS, Ufret-Vincenty CA. Calcium sparklets in arterial smooth muscle. Clin Exp Pharmacol Physiol. 2008;35(9):1121-1126.
29. 2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci USA. 2008;105(40):15623-15628.
30. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52(4): 639-672.
31. Chaplin NL, Amberg GC. Stimulation of arterial smooth muscle L-type calcium channels by hydrogen peroxide requires protein kinase C. Channels (Austin). 2012;6(5):385-389.
32. Naor Z, Benard O, Seger R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab. 2000;11(3):91-99.
33. Sundaresan S, Colin IM, Pestell RG, Jameson JL. Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C. Endocrinology. 1996;137(1):304-311.
34. Bliss SP, Navratil AM, Xie J, Roberson MS. GnRH signaling, the gonadotrope and endocrine control of fertility. Front Neuroendocrinol. 2010;31(3):322-340.
35. 2+ channel activates ERK in MIN6 cells in response to glucagon-like peptide-1. PLoS One. 2012;7(3):e33004.
36. Bliss SP, Navratil AM, Breed M, Skinner DC, Clay CM, Roberson MS. Signaling complexes associated with the type I gonadotropinreleasing hormone (GnRH) receptor: colocalization of extracellularly regulated kinase 2 and GnRH receptor within membrane rafts. Mol Endocrinol. 2007;21(2):538-549.
37. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update. 1997;3(4):359-365.
38. Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst Rev. 2000(2):CD000056.
39. Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100(2):341-348.
40. Tomao F, Lo Russo G, Spinelli GP, et al. Fertility drugs, reproductive strategies and ovarian cancer risk. J Ovarian Res. 2014;7:51.